Company Data

RenovoRx Inc.

Ticker
RNXT
Current Price
$0.96 1.31%
Market Cap
$35.2M
Price Target
Refer to Report
Volume
217.4K
52wk Range
$0.75 - $1.6899
Advanced Market Data

Overview

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy